2019 MACH MRFF

Rapid Applied Research Translation 

Successful Grants & Fellowships

A/Prof Craig Nelson

MACH Partners: University of Melbourne, Western Health (including primary care affiliates)

Project titleFuture Health Today Project-Co-design of Prototype 

 

SummaryFuture Health Today is a novel e-technology platform to extract primary care performance data for clinical audit and decision support to facilitate chronic disease prevention, management and quality improvement.  The goal of Future Health Today (FHT) is to create a new standard-of-care for patients at risk, or diagnosed with chronic diseases, focused on chronic kidney disease (CKD), type 2 diabetes (T2DM) and cardiovascular disease (CVD).

About A/Prof Nelson's Research Project

What is the problem you're trying to solve? 

Nearly half of all Australians have at least one chronic disease such as diabetes, heart disease and chronic kidney disease, and most of these people will attend general practice. Early diagnosis and management is critical to ensure optimal health outcomes and technology has the capacity to facilitate this.

About this research translation project

 

This project has two main aims.

Use health professional and consumer co-design to develop a technology platform (“Future Health Today”) which will be used in general practice for a quality improvement program consisting of audit, feedback and clinical decision support for chronic disease screening, diagnosis and management.

 

Implement and evaluate Future Health Today in ‘real world’ general practice.

The goal of FHT is to create a new standard-of-care in primary care for patients at risk, or diagnosed with chronic diseases, focused on chronic kidney disease (CKD), type 2 diabetes and cardiovascular disease. It will do this by designing and testing an e-technology prototype, a novel platform to extract primary care performance data for clinical audit and decision support to facilitate chronic disease prevention, management and quality improvement.  FHT e-technology will translate learnings from our previous projects EMAP-CKD (2012-2014) and CD IMPACT programs (first pilot 2016-2018), which resulted in improvements in documented disease diagnosis and management utilising small scale delivery methods. FHT will adapt these programs to enable our quality improvement programs to be delivered at scale into the healthcare system, driving systemic and cultural changes to clinical practice, through an implementation science approach. The initial prototype development and testing will focus on CKD detection and management as a proof of concept.

What will be the impact? 

This study will produce a scalable technology which will enable general practices to provide evidence-based, timely management to people at risk of, or who have, chronic disease in order to optimise health and improve quality of life.

RART 2.2 Expansion Activities 

A/Prof Nelson received additional funding in our Rapid Applied Research Translation scheme Round 2 Stage 2 for an expansion on his Stage 1 project. Expansion activities include establishing a randomised clinical trial using the prototype developed in RART 2.1 including plannings and ongoing technology development and revision of the trial protocol based on findings from the pilot.

Download this project summary:

For more information on this project, please contact the MACH office: 

(03) 8344 9973

mach-admin@unimelb.edu.au

ABOUT US

MACH is an NHMRC recognised Advanced Health Research and Translation Centre.

The mission of MACH is to improve health and wellbeing by integrating medical research, education and clinical care.

ADDRESS

187 Grattan Street

Carlton, VIC 3053

 

+61 (0)3 9035 4960

mach-admin@unimelb.edu.au

SUBSCRIBE FOR EMAILS

MACH acknowledges the Traditional Owners of the land on which it works, the Wurundjeri People of the Kulin Nation, and pay respects to its elders past, present and emerging.

All content copyright © 2020 the Melbourne Academic Centre for Health